基于“玄府–内皮屏障”相关性探讨下肢动脉硬化闭塞症的中医病机及开通玄府法的治疗策略
Discussion on TCM Pathogenesis of Lower Extremity Arteriosclerosis Obliterans and Treatment Strategy of Xuanfu-Dredging Method Based on the Correlation between “Xuanfu and Endothelial Barrier”
DOI: 10.12677/tcm.2026.158433, PDF,   
作者: 杨 祯:黑龙江中医药大学研究生院,黑龙江 哈尔滨;陈文阁*:黑龙江中医药大学附属第一医院周围血管病二科,黑龙江 哈尔滨
关键词: 下肢动脉硬化闭塞症玄府内皮屏障玄府闭塞开通玄府风药Lower Extremity Arteriosclerosis Obliterans Xuanfu Endothelial Barrier Xuanfu Obstruction Dredging Xuanfu Wind-Drugs
摘要: 下肢动脉硬化闭塞症是中老年人常见的周围血管疾病,其发病机制复杂,治疗困难。玄府学说是中医理论体系的重要组成部分,近年来受到广泛关注。结合中医整体观念和取象比类思维,本文基于玄府理论与现代内皮屏障研究,提出“玄府–内皮屏障”相关理论,认为中医之玄府与现代医学之血管内皮屏障在结构、功能、病理等方面具有高度相似性。在此基础上,从玄府闭塞的角度深入探讨ASO的中医病机,认为玄府郁闭、气血津液运行不畅是ASO发生发展的核心病机环节,并贯穿于疾病的全过程。进而提出“开通玄府”作为ASO的重要治疗大法,将风药、虫类通络药、芳香开窍药等具有开通玄府作用的药物应用于ASO的治疗,为ASO的中医药防治提供新的理论视角和治疗思路。
Abstract: Lower extremity arteriosclerosis obliterans is a common peripheral vascular disease in middle-aged and elderly people, with complex pathogenesis and difficult treatment. Xuanfu (subtle striae) theory is an important part of the theoretical system of Traditional Chinese Medicine (TCM), which has received extensive attention in recent years. Combining the holistic concept and analogical categorization thinking of TCM, this paper innovatively proposes the “Xuanfu-endothelial barrier” correlation theory based on the Xuanfu theory and modern endothelial barrier research, holding that TCM Xuanfu and modern medical vascular endothelial barrier are highly similar in structure, function and pathology. On this basis, this paper deeply discusses the TCM pathogenesis of ASO from the perspective of Xuanfu obstruction, and believes that Xuanfu stagnation and obstruction, as well as disordered circulation of qi, blood and body fluid, are the core pathogenesis links of ASO, which run through the whole process of the disease. Furthermore, we propose “dredging Xuanfu” as an important therapeutic method for ASO, and apply drugs with Xuanfu-dredging effects such as wind-drugs, worm-type channel-dredging drugs, and aromatic resuscitation drugs to the treatment of ASO, providing a new theoretical perspective and treatment idea for the prevention and treatment of ASO with TCM.
文章引用:杨祯, 陈文阁. 基于“玄府–内皮屏障”相关性探讨下肢动脉硬化闭塞症的中医病机及开通玄府法的治疗策略[J]. 中医学, 2026, 15(8): 253-263. https://doi.org/10.12677/tcm.2026.158433

参考文献

[1] 孙雪薇, 郭伟光, 滕林, 王景, 回雪颖. 中西医结合治疗下肢动脉硬化闭塞症的研究进展[J]. 临床医学进展, 2025, 15(1): 1145-1152.
[2] 栾奕, 高杰. 中医外治法治疗下肢动脉硬化闭塞症研究概况[J]. 中医学, 2022, 11(6): 1097-1103.
[3] 宋翠华, 郭伟光. 中医药治疗下肢动脉硬化闭塞症的研究进展[J]. 中医学, 2022, 11(5): 853-859.
[4] 王明杰, 罗再琼. 玄府学说[M]. 北京: 人民卫生出版社, 2018.
[5] 江玉, 闫颖, 王倩, 王明杰. 玄府学说的发生学研究[J]. 中医杂志, 2017, 58(8): 710-712, 715.
[6] 王志洪, 李丽. 自噬在低剪切力诱导动脉粥样硬化发生发展中的作用[J]. 临床医学进展, 2022, 12(12): 11322-11328.
[7] 高海钧, 任佳禹, 王若琳, 等. 内皮细胞损伤及其功能障碍在动脉粥样硬化中作用的研究进展[J]. 中国全科医学, 2026, 28(21): 2697-2704.
[8] 刘完素. 素问玄机原病式[M]. 北京: 人民卫生出版社, 2013.
[9] 王明杰. “玄府”论[J]. 泸州医学院学报, 1984, 7(3): 1-5.
[10] Xu, W., Xu, T., Long, H., Jiang, Q. and Liao, W. (2026) Occludin-Mediated Barrier Dysfunction and Its Role in Cardiovascular and Cerebrovascular Pathogenesis. Frontiers in Cardiovascular Medicine, 13, Article ID: 1701272.
https://doi.org/10.3389/fcvm.2026.1701272
[11] Feng, Y.Y., Li, C.Y., Chen, J.Y., et al. (2025) Endothelial Dysfunction in Atherosclerosis: From Classical Pathways to Emerging Mechanisms. Vessel Plus, 9, Article 8.
[12] 肖贞良, 孙耕耘. 血管内皮屏障功能调节的研究进展[J]. 生理科学进展, 1998(3): 25-30.
[13] Wang, X. and He, B. (2024) Endothelial Dysfunction: Molecular Mechanisms and Clinical Implications. MedComm, 5, e651.
https://doi.org/10.1002/mco2.651
[14] Neubauer, K. and Zieger, B. (2022) Endothelial Cells and Coagulation. Cell and Tissue Research, 387, 391-398.
https://doi.org/10.1007/s00441-021-03471-2
[15] Wang, W., Chang, S. and Zhao, G. (2025) Endothelial Activation in Thromboangiitis Obliterans: Mechanisms and Therapeutic Horizons. Frontiers in Immunology, 16, Article 1668203.
https://doi.org/10.3389/fimmu.2025.1668203
[16] Pickett, J.R., Wu, Y., Zacchi, L.F., et al. (2023) Targeting Endothelial Vascular Cell Adhesion Molecule-1 in Atherosclerosis: Drug Discovery and Development of VCAM-1-Directed Novel Therapeutics. Cardiovascular Research, 119, 2278-2293.
https://doi.org/10.1093/cvr/cvad130
[17] 江玉, 江花, 张琼, 白雪, 张德绸. 川南玄府学术流派学术思想及临证用药特色[J]. 中华中医药杂志, 2023, 38(7): 3213-3216.
[18] Athavale, A., Fukaya, E. and Leeper, N.J. (2024) Peripheral Artery Disease: Molecular Mechanisms and Novel Therapies. Arteriosclerosis, Thrombosis, and Vascular Biology, 44, 1165-1170.
[19] Gao, Y., Zhang, J., Jiang, N., Wang, L., Cao, T., Xie, Y., et al. (2025) PCSK9 in Peripheral Arterial Disease: Mechanisms and Therapeutic Perspectives. Science Progress, 108.
https://doi.org/10.1177/00368504251370679
[20] 张宁, 陈文阁. 基于《黄帝内经》以“虚邪痰瘀”探析下肢动脉硬化闭塞症[J]. 中医学, 2023, 12(8): 2289-2295.
[21] 高华阳, 郭伟光, 回雪颖, 等. 基于玄府的理论阐述三九贴在寒凝血瘀型脱疽中的应用[J]. 临床医学进展, 2024, 14(7): 1271-1274.
[22] 钟森杰, 李静, 王陵军, 陈梓欣, 吴辉, 陈洁, 方红城, 冼绍祥. 基于痰瘀相关理论探讨冠心病脂质浸润机制及痰瘀同治的研究进展[J]. 中国中药杂志, 2023, 48(6): 1431-1437.
[23] 郭嘉欣, 孙秋. 化瘀通络类方治疗下肢动脉硬化闭塞症的研究进展[J]. 临床医学进展, 2025, 15(8): 1134-1140.
[24] 胡明煊, 周海纯. 下肢动脉硬化闭塞症中西医治疗研究进展[J]. 临床个性化医学, 2024, 3(3): 788-792.
[25] 谷欣月, 郭伟光. 黄连温胆汤治疗寒地下肢动脉硬化闭塞症湿热下注的临床经验分析[J]. 临床个性化医学, 2026, 5(3): 347-355.
[26] Zhou, M., Yu, Y., Chen, R., Liu, X., Hu, Y., Ma, Z., et al. (2023) Wall Shear Stress and Its Role in Atherosclerosis. Frontiers in Cardiovascular Medicine, 10, Article 1083547.
https://doi.org/10.3389/fcvm.2023.1083547
[27] Cheng, C.K., Wang, N., Wang, L. and Huang, Y. (2025) Biophysical and Biochemical Roles of Shear Stress on Endothelium: A Revisit and New Insights. Circulation Research, 136, 752-772.
https://doi.org/10.1161/circresaha.124.325685
[28] 闫颖, 王倩, 江玉, 王明杰. 王明杰从玄府论治椎-基底动脉供血不足性眩晕的经验[J]. 中华中医药杂志, 2016, 31(8): 3135-3137.
[29] 陈达夫. 中医眼科六经法要[M]. 成都: 四川人民出版社, 1978.
[30] 常富业, 王永炎, 高颖, 杨宝琴. 论开通玄府[J]. 中国临床康复, 2005, 9(39): 128-129, 132.
[31] 江玉, 江花, 王倩, 闫颖, 王明杰. 王明杰教授开通玄府治疗外眼病的经验[J]. 中华中医药杂志, 2014, 29(1): 168-170.
[32] 江玉, 尚宗明, 闫颖, 王倩. 王明杰从玄府论治下肢动脉硬化闭塞症经验[J]. 中国中医基础医学杂志, 2019, 25(1): 105-107.
[33] Chen, L., Qu, H., Liu, B., Chen, B., Yang, Z., Shi, D., et al. (2024) Low or Oscillatory Shear Stress and Endothelial Permeability in Atherosclerosis. Frontiers in Physiology, 15, Article 1432719.
https://doi.org/10.3389/fphys.2024.1432719
[34] Li, K., Feng, J., Li, M., Han, L. and Wu, Y. (2025) Systematic Review of Interleukin‐35 in Endothelial Dysfunction: A New Target for Therapeutic Intervention. Mediators of Inflammation, 2025, Article ID: 2003124.
https://doi.org/10.1155/mi/2003124